Skip to content
10-K

Annual Report

NASCENT BIOTECH, INC.

0001477932-24-004020

← back to feed
Filed
Jul 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jun 28, 2024 172.2M sh
Operating Cash Flow FY 2024 · Mar 31, 2024 −$1.19M
Stockholders Equity FY 2024 · Mar 31, 2024 −$256.67K
Current Liabilities FY 2024 · Mar 31, 2024 $808.79K
Total Liabilities FY 2024 · Mar 31, 2024 $808.79K
Current Assets FY 2024 · Mar 31, 2024 $552.12K
Total Assets FY 2024 · Mar 31, 2024 $552.12K
Rd Expense FY 2024 · Mar 31, 2024 $110.98K
Net Income FY 2024 · Mar 31, 2024 −$2.09M
Operating Income FY 2024 · Mar 31, 2024 −$2.23M